Untargeted LC–HRMS of Dried Blood Spots Reveals Metabolic Alterations and Candidate Biomarkers in Glutaric Aciduria Type-1

Read full text Summarise with VIRAT
Authors: Ahmed H. Mujamammi, Tagreed A. Mazi, Reem H. AlMalki, Essa Mohammed Sabi, Maha Al Mogren, Meshari M. S. Alwazae, Randh AlAhmari, Khalid M. Sumaily, Rajaa Sebaa, Anas M. Abdel Rahman
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Glutaric aciduria type-1 (GA-1) is a genetic disorder caused by glutaryl-coenzyme A dehydrogenase deficiency, leading to the accumulation of glutaryl-CoA and its derivatives. Clinical manifestations include neurological abnormalities; however, the underlying pathological mechanisms remain unclear. Early diagnosis and intervention are crucial for minimizing adverse outcomes. To date, diagnostic methods have certain limitations, and there is a critical need for a sensitive biomarker for diagnosis. We aimed to characterize metabolic dysregulation and identify candidate biomarkers associated with GA-1 in biochemically confirmed patients compared to age- and sex-matched control subjects. Methodology: Untargeted metabolomics profiling of GA-1 patients (n = 29) was compared to matched control subjects by age and sex. Multivariate and univariate statistical analyses were performed to identify dysregulated metabolites. Results: Our findings revealed 220 endogenous human metabolites. Notably, there was a strong enrichment in carboxylic acids and derivatives, including amino acids and derivatives, hydroxy and keto acids, fatty acyls, sphingolipids, phosphatidylcholines, and nucleotides and nucleosides. Pathway analysis indicates alterations in the biosynthesis of cardiolipin and phosphatidylcholine, as well as in pyrimidine metabolism, the urea cycle, and amino sugar metabolism. We demonstrated a robust performance model for 6-Methylnonanoyl-CoA, displaying strong discriminative power. Conclusions: We identified broad dysregulation across various biochemical classes, reflecting an imbalance in energy metabolism that involves carbohydrate and lipid pathways. The results also highlight dysregulation in sphingolipids, phospholipids, and nucleotide metabolism. These findings are preliminary and the clinical relevance of these findings in patients with GA-1 requires further investigation. We identified candidate biomarkers capable of distinguishing GA-1 patients from controls; however, these findings require validation in independent cohorts.

Fields of Study & Subjects

Metabolism and Genetic Disorders Metabolomics and Mass Spectrometry Studies Lysosomal Storage Disorders Research

Publication details

Journal / source
Metabolites
Volume
16
Issue
3
Pages
214–214
Publication date
23 March 2026
Language
EN